An observational study in Sterility, sponsored by Ferring Pharmaceuticals. Completed at 7 sites in Spain. Open to female participants aged 18 Years to 36 Years. Per ClinicalTrials.gov, last updated 2011-04-08.
Sponsored by Ferring Pharmaceuticals · Observational
To assess the effectiveness of protocols of ovarian hyperstimulation combining urinary gonadotrophins + GnRH antagonist vs urinary gonadotrophins, to achieve clinical pregnancy in females undergoing intrauterine insemination.
Study hypothesis: protocols combining urinary gonadotrophins + GnRH antagonist should be more effective than monotherapy.
2,541 studies on the registry are indexed under Infertility; 405 are open to participants now.
This study's enrollment of 131 is below the median of 200 across 722 observational studies indexed under Infertility.
Browse Infertility studies →Ferring Pharmaceuticals is the lead sponsor of 249 studies on the registry; 4 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 14 (93%) have results posted.
Counted across the registry records on this site, refreshed daily.
Females affected by sterility able to undergo intrauterine insemination
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with a condition
Drug: hMG-HP
Patients with a condition
Drug: hMG + GnRH antagonist
Clinical pregnancy rate
Time frame: 30 days
Live birth rate
Time frame: 40 weeks
This study is completed, as verified in Apr 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.